Woynarowski JM - Search Results

1

Region-specific DNA damage by AT-specific DNA-reactive drugs is predicted by drug binding specificity.

Woynarowski JM, Napier C, Trevino AV, Arnett B. Woynarowski JM, et al. Biochemistry. 2000 Aug 15;39(32):9917-27. doi: 10.1021/bi000729k. Biochemistry. 2000. PMID: 10933811

2

The genome factor in region-specific DNA damage: the DNA-reactive drug U-78779 prefers mixed A/T-G/C sequences at the nucleotide level but is region-specific for long pure AT islands at the genomic level.

Herzig MC, Rodriguez KA, Trevino AV, Dziegielewski J, Arnett B, Hurley L, Woynarowski JM. Herzig MC, et al. Among authors: woynarowski jm. Biochemistry. 2002 Feb 5;41(5):1545-55. doi: 10.1021/bi011907s. Biochemistry. 2002. PMID: 11814348

3

Induction of AT-specific DNA-interstrand crosslinks by bizelesin in genomic and simian virus 40 DNA.

Woynarowski JM, Chapman WG, Napier C, Herzig MC. Woynarowski JM, et al. Biochim Biophys Acta. 1999 Feb 16;1444(2):201-17. doi: 10.1016/s0167-4781(99)00002-0. Biochim Biophys Acta. 1999. PMID: 10023060

4

Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific.

Herzig MC, Trevino AV, Arnett B, Woynarowski JM. Herzig MC, et al. Among authors: woynarowski jm. Biochemistry. 1999 Oct 19;38(42):14045-55. doi: 10.1021/bi991286r. Biochemistry. 1999. PMID: 10529251

5

Oxaliplatin-induced damage of cellular DNA.

Woynarowski JM, Faivre S, Herzig MC, Arnett B, Chapman WG, Trevino AV, Raymond E, Chaney SG, Vaisman A, Varchenko M, Juniewicz PE. Woynarowski JM, et al. Mol Pharmacol. 2000 Nov;58(5):920-7. doi: 10.1124/mol.58.5.920. Mol Pharmacol. 2000. PMID: 11040038

6

AT-rich islands in genomic DNA as a novel target for AT-specific DNA-reactive antitumor drugs.

Woynarowski JM, Trevino AV, Rodriguez KA, Hardies SC, Benham CJ. Woynarowski JM, et al. J Biol Chem. 2001 Nov 2;276(44):40555-66. doi: 10.1074/jbc.M103390200. Epub 2001 Aug 3. J Biol Chem. 2001. PMID: 11487576 Free article.

7

Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA.

Woynarowski JM, Chapman WG, Napier C, Herzig MC, Juniewicz P. Woynarowski JM, et al. Mol Pharmacol. 1998 Nov;54(5):770-7. doi: 10.1124/mol.54.5.770. Mol Pharmacol. 1998. PMID: 9804612

8

Apoptosis induction by the dual-action DNA- and protein-reactive antitumor drug irofulven is largely Bcl-2-independent.

Herzig MC, Trevino AV, Liang H, Salinas R, Waters SJ, MacDonald JR, Woynarowska BA, Woynarowski JM. Herzig MC, et al. Among authors: woynarowski jm. Biochem Pharmacol. 2003 Feb 15;65(4):503-13. doi: 10.1016/s0006-2952(02)01552-6. Biochem Pharmacol. 2003. PMID: 12566077

9

Matrix attachment region (MAR) properties and abnormal expansion of AT island minisatellites in FRA16B fragile sites in leukemic CEM cells.

Jackson JA, Trevino AV, Herzig MC, Herman TS, Woynarowski JM. Jackson JA, et al. Among authors: woynarowski jm. Nucleic Acids Res. 2003 Nov 1;31(21):6354-64. doi: 10.1093/nar/gkg832. Nucleic Acids Res. 2003. PMID: 14576323 Free PMC article.

10

Cell cycle effects and induction of premitotic apoptosis by irofulven in synchronized cancer cells.

Woynarowski JM, Woynarowska BA, Trevino AV, Salinas R, Herman TS, Waters SJ, Macdonald JR. Woynarowski JM, et al. Cancer Biol Ther. 2004 Nov;3(11):1137-42; discussion 1143-4. doi: 10.4161/cbt.3.11.1216. Epub 2004 Nov 9. Cancer Biol Ther. 2004. PMID: 15467441 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters